11 results on '"B. Otová"'
Search Results
2. Inhibitory effect of FK 506 and cyclosporin A on nitric oxide production by LPS-treated cultured rat macrophages
- Author
-
P, Strestíková, B, Otová, M, Filipec, and H, Farghali
- Subjects
Lipopolysaccharides ,Male ,Macrophage Activation ,Nitric Oxide ,Tacrolimus ,Rats ,Cyclosporine ,Escherichia coli ,Macrophages, Peritoneal ,Animals ,Rats, Wistar ,Cells, Cultured ,Immunosuppressive Agents ,Nitrites - Abstract
We analyzed the effect of FK 506 on the production of nitric oxide by macrophages. Isolated rat peritoneal macrophages were cultured for 24 h with or without lipopolysaccharide (LPS) (5 microg/ml) and in the absence or presence of FK 506 (0.1 and 1 microg/ml). The concentration of NO2- in culture supernatants was taken as a measure of nitric oxide production. FK 506 (0.1 and 1 microg/ml) reduced the LPS-induced increase of NO2- levels by 68% and 81%, respectively. The impact of cyclosporin A (CsA) was studied in order to compare their effects. CsA (0.1 and 1 microg/ml) decreased the levels of nitrites by 39% and 69%, respectively. The results obtained suggest that both immunosuppressive drugs exhibit a dose-dependent inhibitory effect on nitric oxide production and that FK 506 is a more potent agent than CsA in this respect.
- Published
- 2001
3. Therapeutic effect of heat shock on T-cell lymphoma in inbred Sprague-Dawley rat
- Author
-
B, Otová, M, Mráz, V, Mandys, A, Panczak, J, Schramlová, I, Votruba, and A, Holy
- Subjects
Male ,Antimetabolites, Antineoplastic ,Adenine ,Body Weight ,Apoptosis ,HSP72 Heat-Shock Proteins ,Hyperthermia, Induced ,Lymphoma, T-Cell ,Combined Modality Therapy ,Neoplasm Proteins ,Rats ,Rats, Sprague-Dawley ,Proto-Oncogene Proteins c-bcl-2 ,Cryotherapy ,Neoplastic Syndromes, Hereditary ,Stress, Physiological ,Immersion ,Animals ,Female ,Tumor Suppressor Protein p53 ,Heat-Shock Proteins ,Neoplasm Transplantation - Abstract
Anticancer effect of heat shock, either alone or in combination with the drug PMEDAP, and cold water immersion stress were studied in an in vivo model of s.c. transplanted rat T-cell lymphomas in an inbred Sprague-Dawley rat line (SD/cub). Significant anticancer effect was induced by repeated sessions of heat shock; decrease of s.c. lymphoma weight and prolongation of survival time of treated rats was found to be dependent on the number of HS sessions. Much stronger therapeutic effect was observed after repeated heat shock in combination with PMEDAP administration. Light and electron microscopy studies were performed to characterize the alterations within the lymphomas. Morphologically, cellular alterations corresponding with apoptosis were observed in lymphoma cells after repeated heat shock. Indirect immunoperoxidase technique was used to detect HSP 72/73 protein(s), p53 and Bcl2 proteins in lymphomas heated directly or indirectly. The induction of HSP 72/73 protein(s) was found in the lymphoma tissues from autopsied animals exposed to heat shock; the intensity of its expression was dependent on the experimental design. The expression of p53 and BcL2 proteins was not changed in lymphoma cells of HS treated animals as compared to that of untreated lymphoma bearing controls; the Bcl2 protein was present in both treated and untreated lymphomas, and the p53 protein remained undetectable in all samples. Contrary to the heat shock, the cold stress did not suppress growth of lymphomas and, furthermore, accelerated the infiltration of parenchymatous organs with lymphoma cells.
- Published
- 2000
4. Cytogenetic changes in Sprague-Dawley rat lymphomas in the course of in vivo passages
- Author
-
M, Sladká and B, Otová
- Subjects
Chromosome Aberrations ,Male ,Time Factors ,Lymphoma ,Bone Marrow Cells ,Chromosome Banding ,Rats ,Rats, Sprague-Dawley ,Cytogenetics ,Transplantation, Isogeneic ,Karyotyping ,Animals ,Female ,Neoplasm Transplantation - Abstract
Changes in the karyotype in three spontaneous Sprague-Dawley rat lymphomas (SD7/95, SD8/96, SD9/96) have been studied in the course of in vivo passages. In individual lymphomas karyological findings of primary disease from lymph nodes were compared with changes found in the 1st and 10th passages of the lymphoma and bone marrow samples. Chromosome studies were performed on direct preparations using the G-banding technique. Chromosome counts of all specimens studied were near diploidy, the majority of metaphase cells being pseudodiploid. In later passages of two lymphomas, the tendency in selection to hyperdiploid karyotype, particularly in bone marrow was observed. The examination revealed an increased percentage of breaks in lymph node cells of primary disease and the existence of nonrandom change, derivative chromosome 11, which occurred in structural variability in all three lymphomas studied. The aberration involving chromosome 11 was evaluated as the addition of unknown material at chromosome band 11q11 or as a duplication or triplication of segment 11q12-q23. If this structural aberration was not found, the excessive derivative chromosome 11 or translocation t(11;13) was proved to be present. Further, rearrangements of chromosomes 13 and 7 were nonrandom chromosome abnormalities revealed in later passages of the lymphomas. The results are in accordance with our previous observations in 14 cases of SD lymphomas that showed nonrandom occurrence of rearrangements concerning chromosome 11 and also relatively frequent translocation involving chromosome 13.
- Published
- 2000
5. Antitumor activity of novel purine acyclic nucleotide analogs PMEA and PMEDAP
- Author
-
B, Otová, Z, Zídek, A, Holý, I, Votruba, M, Sladká, I, Marinov, and V, Lesková
- Subjects
Adenine ,CD4-CD8 Ratio ,Antineoplastic Agents ,Lymphoma, T-Cell ,Antiviral Agents ,Rats ,Rats, Sprague-Dawley ,Mice ,Animals ,Humans ,Lung ,Cell Division ,Cells, Cultured ,Injections, Intraperitoneal ,Spleen - Abstract
PMEDAP and/or PMEA treatment of SD rat lymphomas significantly prolonged the mean survival time of tumor-bearing animals. Dose-dependent genotoxicity of both PMEDAP and PMEA was not observed in in vitro tests on stabilized diploid MRC-5 cell line. The mitotic activity of MRC-5 cells was completely inhibited after 48 hours exposure in culture medium containing PMEDAP (10 micrograms/ml), or PMEA (25 micrograms/ml), respectively. Significant concentration dependent inhibition of cell proliferation caused by PMEDAP and/or PMEA was also observed in murine splenocytes. The analogs specifically inhibit proliferation of mitogen-activated T-lymphocytes. Modulation of subpopulations of peripheral blood cells under in vivo conditions was found in inbred SD animals. Intraperitoneal administration of PMEDAP to young healthy SD animals induced the decrease of the CD4+/CD8+ value from 1.3-1.6 to 0.72 while i.p. application of PMEA caused a decrease of the same ratio to 0.62.
- Published
- 1997
6. In vivo modulation of angiogenic gene expression by acyclic nucleoside phosphonates PMEDAP and PMEG.
- Author
-
Otová B, Hrdy J, Votruba I, and Holy A
- Subjects
- Adenine pharmacology, Animals, Epidermal Growth Factor genetics, Epidermal Growth Factor metabolism, ErbB Receptors genetics, ErbB Receptors metabolism, Fibroblast Growth Factor 1 genetics, Fibroblast Growth Factor 1 metabolism, Guanine pharmacology, Lymphoma, T-Cell genetics, Male, Platelet-Derived Growth Factor genetics, Platelet-Derived Growth Factor metabolism, RNA, Messenger genetics, RNA, Messenger metabolism, Rats, Rats, Sprague-Dawley, Receptor, Fibroblast Growth Factor, Type 1 genetics, Receptor, Fibroblast Growth Factor, Type 1 metabolism, Receptor, Platelet-Derived Growth Factor beta genetics, Receptor, Platelet-Derived Growth Factor beta metabolism, Reverse Transcriptase Polymerase Chain Reaction, Vascular Endothelial Growth Factor A genetics, Vascular Endothelial Growth Factor A metabolism, Vascular Endothelial Growth Factor Receptor-1 genetics, Vascular Endothelial Growth Factor Receptor-1 metabolism, Adenine analogs & derivatives, Gene Expression Regulation, Neoplastic drug effects, Guanine analogs & derivatives, Lymphoma, T-Cell metabolism, Lymphoma, T-Cell pathology, Neovascularization, Pathologic metabolism, Organophosphorus Compounds pharmacology
- Abstract
Acyclic nucleoside phosphonates PMEDAP and PMEG modulate expression of selected proangiogenic genes in SD-lymphoma bearing rats. Antiangiogenic efficacy of PMEDAP is relatively weak and is manifested mainly by down-regulation of vascular endothelial growth factor (VEGF) and its receptor VEGFR detectable 24 hours after treatment. Compound PMEG (an active metabolite of the prodrug GS-9219) down-regulates selected proangiogenic genes EGF, FGF, PDGF, VEGF, EGFR, FGFR, PDGFR and VEGFR much more efficiently. Its antiangiogenic potency persists and is more intensive 48 hours after treatment. Findings show that in vivo antitumour efficacy of both antimitotic acyclic nucleoside phosphonates PMEDAP and PMEG consequently affect the angiogenesis in T-cell lymphoma.
- Published
- 2009
7. Experimental therapy with 9-[2-(phosphonomethoxy)ethyl]-2,6-diaminopurine (PMEDAP): origin of resistance.
- Author
-
Zápotocký M, Hanzalová J, Starková J, Votruba I, Holý A, and Otová B
- Subjects
- Adenine therapeutic use, Animals, Cell Line, Tumor, Gene Expression Regulation, Neoplastic, Humans, Lymphoma genetics, Male, Multidrug Resistance-Associated Proteins genetics, Multidrug Resistance-Associated Proteins metabolism, Neoplasm Transplantation, Organ Size, Rats, Rats, Sprague-Dawley, Transcriptional Activation, Adenine analogs & derivatives, Antineoplastic Agents therapeutic use, Drug Resistance, Neoplasm, Lymphoma drug therapy
- Abstract
The role of MRP4 and MRP5 transporters in the acyclic nucleoside phosphonate PMEDAP efflux was studied in vitro (CCRF-CEM cells) and in vivo (spontaneous transplantable T-cell lymphoma of SD/Cub inbred rats). The increased resistance against the cytostatic agent PMEDAP during longterm treatment was found to be associated with overexpression of MRP4 and MRP5 genes. The course of both gene activation differs significantly. While the MRP5 function is important in the onset of PMEDAP resistance, the intensity of the relative MRP4 gene expression increases rather continuously. Our data indicate cooperative acting of both MRP4 and MRP5 genes during the PMEDAP resistance development.
- Published
- 2007
8. Tenofovir diphosphate is a poor substrate and a weak inhibitor of rat DNA polymerases alpha, delta, and epsilon*.
- Author
-
Birkus G, Hájek M, Kramata P, Votruba I, Holý A, and Otová B
- Subjects
- Adenine pharmacology, Animals, Anti-HIV Agents pharmacology, DNA Polymerase I antagonists & inhibitors, DNA Polymerase I metabolism, DNA Polymerase II antagonists & inhibitors, DNA Polymerase II metabolism, DNA Polymerase III antagonists & inhibitors, DNA Polymerase III metabolism, Organophosphorus Compounds pharmacology, Rats, Reverse Transcriptase Inhibitors pharmacology, Tenofovir, Adenine analogs & derivatives, Adenine metabolism, Anti-HIV Agents metabolism, DNA-Directed DNA Polymerase metabolism, Nucleic Acid Synthesis Inhibitors, Organophosphonates, Organophosphorus Compounds metabolism, Reverse Transcriptase Inhibitors metabolism
- Abstract
Tenofovir diphosphate (PMPApp) is a weak inhibitor of DNA polymerases (pol) alpha, delta, and epsilon*, with values for the Ki for PMPApp ((PMPApp)Ki) relative to the Km for dATP ((dATP)Km) of 10.2, 10.2, and 15.2, respectively. Its incorporation into DNA was about 1,000-fold less efficient than that of dATP, with (PMPApp)Km values 350-, 2,155-, and 187-fold higher than (dATP)Km values for pol alpha, delta, and epsilon*, respectively.
- Published
- 2002
- Full Text
- View/download PDF
9. Relevant animal model of human lymphoblastic leukaemia/lymphoma--spontaneous T-cell lymphomas in an inbred Sprague-Dawley rat strain (SD/Cub).
- Author
-
Otová B, Sladká M, Damoiseaux J, Panczak A, Mandys V, and Marinov I
- Subjects
- Aging physiology, Animals, Antineoplastic Agents therapeutic use, Humans, Immunophenotyping, Rats, Rats, Sprague-Dawley, Survival Rate, Disease Models, Animal, Leukemia-Lymphoma, Adult T-Cell drug therapy, Leukemia-Lymphoma, Adult T-Cell genetics, Leukemia-Lymphoma, Adult T-Cell pathology, Leukemia-Lymphoma, Adult T-Cell physiopathology, Precursor Cell Lymphoblastic Leukemia-Lymphoma drug therapy, Precursor Cell Lymphoblastic Leukemia-Lymphoma genetics, Precursor Cell Lymphoblastic Leukemia-Lymphoma pathology, Precursor Cell Lymphoblastic Leukemia-Lymphoma physiopathology
- Abstract
More than a decade of experimental work in an inbred subline of Sprague-Dawley rats having high incidence of spontaneous T-cell lymphoma/leukaemia is reviewed. Longitudinal follow-up of biological characteristics (growth, survival, haematology) of both multiple cases of primary disease and s.c. passaged lymphomas as well as comparative immunophenotypic and karyotypic studies are concluded. In these T-cell lymphomas (mostly CD4 positive), arising on the same genetic background of the inbred SD strain, the aberrations involving chromosome 11 have been recognized as a typical non-random cytogenetic marker. This unique rat model of lymphoblastic lymphomas/leukaemias, relevant to human pathology, seems to be very suitable for testing different anticancer therapeutic strategies, as it is documented by results of a number of various protocols conducted in our laboratory.
- Published
- 2002
10. Inhibitory effect of FK 506 and cyclosporin A on nitric oxide production by LPS-treated cultured rat macrophages.
- Author
-
Strestíková P, Otová B, Filipec M, and Farghali H
- Subjects
- Animals, Cells, Cultured, Escherichia coli, Macrophage Activation, Macrophages, Peritoneal metabolism, Male, Nitrites analysis, Rats, Rats, Wistar, Cyclosporine pharmacology, Immunosuppressive Agents pharmacology, Lipopolysaccharides pharmacology, Macrophages, Peritoneal drug effects, Nitric Oxide biosynthesis, Tacrolimus pharmacology
- Abstract
We analyzed the effect of FK 506 on the production of nitric oxide by macrophages. Isolated rat peritoneal macrophages were cultured for 24 h with or without lipopolysaccharide (LPS) (5 microg/ml) and in the absence or presence of FK 506 (0.1 and 1 microg/ml). The concentration of NO2- in culture supernatants was taken as a measure of nitric oxide production. FK 506 (0.1 and 1 microg/ml) reduced the LPS-induced increase of NO2- levels by 68% and 81%, respectively. The impact of cyclosporin A (CsA) was studied in order to compare their effects. CsA (0.1 and 1 microg/ml) decreased the levels of nitrites by 39% and 69%, respectively. The results obtained suggest that both immunosuppressive drugs exhibit a dose-dependent inhibitory effect on nitric oxide production and that FK 506 is a more potent agent than CsA in this respect.
- Published
- 2000
11. Lack of causal relationship between inducibility/severity of adjuvant arthritis in the rat and disease associated changes in production of nitric oxide by macrophages.
- Author
-
Zídek Z, Franková D, and Otová B
- Subjects
- Animals, Cells, Cultured, Female, Lipopolysaccharides pharmacology, Macrophage Activation physiology, Rats, Rats, Inbred BN, Rats, Inbred F344, Rats, Inbred Lew, Time Factors, Arthritis, Experimental metabolism, Macrophages, Peritoneal metabolism, Nitric Oxide biosynthesis
- Abstract
Objective: To investigate the formation of nitric oxide (NO) by peritoneal macrophages in three inbred strains of rats differing both in their susceptibility to the induction of adjuvant arthritis (AA) and in the severity of the disease., Methods: AA was induced by intraplantar injection of Mycobacterium tuberculosis (M.tb) in paraffin oil. Isolated peritoneal macrophages were cultured for 24 hours and supernatants were assayed for nitrite using Griess reagent., Results: All rats of the LEW and BN strains became diseased, but the F344 strain included both responders and non-responders. No significant interstrain differences were observed in the generation of NO by macrophages from control animals. Nitrite concentrations were remarkably enhanced in all M.tb treated animals, regardless of the absence or presence of AA, and did not parallel its severity. Altered production of NO by macrophages from adjuvant treated rats was normalised in vitro in the presence of lipopolysaccharide., Conclusions: Our findings suggest that the activity of constitutive or inducible NO synthase in peritoneal macrophages cannot be regarded as a determinant of genetically controlled disease inducibility and severity. Secretion of latent forms of certain NO downregulatory factors during development of AA may be implicated.
- Published
- 1995
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.